Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-17-000337
Filing Date
2017-05-15
Accepted
2017-05-15 08:35:46
Documents
71
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10Q aoxing.htm 10-Q 560655
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 exh31_1.htm EX-31.1 12502
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 exh31_2.htm EX-31.2 12552
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. exh32_1.htm EX-32.1 5305
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. exh32_2.htm EX-32.2 5388
  Complete submission text file 0001096906-17-000337.txt   2878839

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axn-20170331.xml EX-101.INS 576661
7 XBRL TAXONOMY EXTENSION SCHEMA axn-20170331.xsd EX-101.SCH 35452
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axn-20170331_cal.xml EX-101.CAL 31410
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axn-20170331_def.xml EX-101.DEF 54243
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE axn-20170331_lab.xml EX-101.LAB 172473
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axn-20170331_pre.xml EX-101.PRE 153946
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 17841300
SIC: 2834 Pharmaceutical Preparations